Cargando…
Partial response to dabrafenib and trametinib in relapsed BRAF V600E-Mutated multiple myeloma and possible mechanisms of resistance
BRAF V600E mutations are detected in 3%–10% of patients with multiple myeloma (MM) and are associated with more aggressive disease, higher frequency of extramedullary growth and shorter survival. Monotherapy with the BRAF inhibitor vemurafenib has been disappointing in MM. In patients with BRAF-muta...
Autores principales: | Ernst, Tina, Aebi, Stefan, Zander, Andrea, Zander, Thilo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996037/ https://www.ncbi.nlm.nih.gov/pubmed/35396243 http://dx.doi.org/10.1136/bcr-2021-246264 |
Ejemplares similares
-
Caffeine to prevent respiratory failure and improve outcome in infant pertussis
por: Evered, John, et al.
Publicado: (2018) -
Re-correction osteotomy with osteophyte graft for correction loss with non-union after high tibial osteotomy
por: Nakamura, Ryuichi, et al.
Publicado: (2017) -
Successful downstaging of locally recurrent penile squamous cell carcinoma with neoadjuvant nanosomal docetaxel lipid suspension (NDLS) based regimen followed by curative surgery
por: Gupta, Sameer, et al.
Publicado: (2017) -
Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia
por: Ogawa, Tatsuhiko
Publicado: (2017) -
Use of a dynamic gait trainer for a child with thoracic level spinal cord injury
por: Altizer, Wendy, et al.
Publicado: (2017)